Nihon Kohden Corporation (TYO:6849)
2,227.50
-79.00 (-3.43%)
Feb 20, 2025, 3:21 PM JST
Nihon Kohden Revenue
Nihon Kohden had revenue of 55.69B JPY in the quarter ending December 31, 2024, with 5.81% growth. This brings the company's revenue in the last twelve months to 224.29B, up 2.79% year-over-year. In the fiscal year ending March 31, 2024, Nihon Kohden had annual revenue of 221.99B with 7.45% growth.
Revenue (ttm)
224.29B
Revenue Growth
+2.79%
P/S Ratio
1.65
Revenue / Employee
38.07M
Employees
5,891
Market Cap
363.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 221.99B | 15.38B | 7.45% |
Mar 31, 2023 | 206.60B | 1.47B | 0.72% |
Mar 31, 2022 | 205.13B | 5.40B | 2.70% |
Mar 31, 2021 | 199.73B | 14.72B | 7.96% |
Mar 31, 2020 | 185.01B | 6.21B | 3.47% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |